114 participants
An Open-Label, Single Arm Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-04-04
- Start Date:
- 2019-02-26
- Completion:
- 2020-08-04
Conditions
- Advanced Follicular Lymphoma
Interventions
- DRUG